New research has uncovered new insights into why the most aggressive esophageal cancers are so difficult to treat and how the body's own defense systems are helping them to thrive. The study, led by Professor Eileen Parkes ...
Mar 16, 2026
0
7
A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic intent, but real-time activity. By measuring RNA and proteins simultaneously, it reveals cytokine ...
Apr 8, 2026
0
7
A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) have found a way to switch it back on. In a study published in Science Translational Medicine, the team reveals ...
Apr 2, 2026
0
7
When 12-year-olds receive a letter from the school nurse about the HPV vaccine, their reactions are often mixed. Some students worry about the needle. Others wonder why they need a vaccine for something they have never heard ...
Mar 16, 2026
0
7
A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and experienced less short-term impact on their daily lives when treated with MRI-guided, transurethral ...
Apr 13, 2026
0
7
A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. The approach uses single-cell reference ...
Mar 20, 2026
0
7
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as "reassuring" in a presentation at the 15th European Breast Cancer Conference (EBCC15) in Barcelona.
Mar 26, 2026
0
7
A new University of Kentucky study has mapped areas across the U.S. where high rates of diabetes and deaths from diabetes-related cancers overlap. The UK Markey Cancer Center and Barnstable Brown Diabetes Center research ...
Mar 5, 2026
0
7
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own immune arsenal to fight ...
Mar 19, 2026
0
7
Liver cancer in children is rare, but when it occurs, the two main types are hepatoblastoma (HB) and hepatocellular carcinoma (HCC). In some cases, however, the tumors show features of both types. These tumors have been classified ...
Mar 16, 2026
0
7
